Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 68

1.

Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial.

Schepers NJ, Bakker OJ, Besselink MG, Bollen TL, Dijkgraaf MG, van Eijck CH, Fockens P, van Geenen EJ, van Grinsven J, Hallensleben ND, Hansen BE, van Santvoort HC, Timmer R, Anten MP, Bolwerk CJ, van Delft F, van Dullemen HM, Erkelens GW, van Hooft JE, Laheij R, van der Hulst RW, Jansen JM, Kubben FJ, Kuiken SD, Perk LE, de Ridder RJ, Rijk MC, Römkens TE, Schoon EJ, Schwartz MP, Spanier BW, Tan AC, Thijs WJ, Venneman NG, Vleggaar FP, van de Vrie W, Witteman BJ, Gooszen HG, Bruno MJ; Dutch Pancreatitis Study Group.

Trials. 2016 Jan 5;17(1):5. doi: 10.1186/s13063-015-1132-0.

2.

[A woman with painful ulcera on her lower leg].

Schreuder RM, Horváth B, van Dullemen HM.

Ned Tijdschr Geneeskd. 2015;159:A8783. Dutch.

PMID:
26131750
3.

A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ; Dutch research group on pancreatic cancer surveillance in high-risk individuals.

Gut. 2015 May 18. pii: gutjnl-2014-308008. doi: 10.1136/gutjnl-2014-308008. [Epub ahead of print]

PMID:
25986944
4.

EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.

van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Kema IP, Koopmans KP, Valk GD, Timmers HJ, de Herder WW, Feelders RA, Fockens P, Sluiter WJ, de Vries EG, Links TP.

Gastrointest Endosc. 2015 Jan;81(1):159-167.e2. doi: 10.1016/j.gie.2014.09.037.

PMID:
25527055
5.

Dutch Chronic Pancreatitis Registry (CARE): design and rationale of a nationwide prospective evaluation and follow-up.

Ahmed Ali U, Issa Y, van Goor H, van Eijck CH, Nieuwenhuijs VB, Keulemans Y, Fockens P, Busch OR, Drenth JP, Dejong CH, van Dullemen HM, van Hooft JE, Siersema PD, Spanier BW, Poley JW, Poen AC, Timmer R, Seerden T, Tan AC, Thijs WJ, Witteman BJ, Romkens TE, Roeterdink AJ, Gooszen HG, van Santvoort HC, Bruno MJ, Boermeester MA; Dutch Pancreatitis Study Group.

Pancreatology. 2015 Jan-Feb;15(1):46-52. doi: 10.1016/j.pan.2014.11.002. Epub 2014 Nov 29.

PMID:
25511908
6.

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).

Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, Ponsioen CI, van Dullemen HM, Russel M, van Bodegraven AA, van der Woude CJ.

Gut. 2014 Feb;63(2):292-9. doi: 10.1136/gutjnl-2013-304488. Epub 2013 Mar 23.

PMID:
23525574
7.

Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial.

Ahmed Ali U, Issa Y, Bruno MJ, van Goor H, van Santvoort H, Busch OR, Dejong CH, Nieuwenhuijs VB, van Eijck CH, van Dullemen HM, Fockens P, Siersema PD, Gouma DJ, van Hooft JE, Keulemans Y, Poley JW, Timmer R, Besselink MG, Vleggaar FP, Wilder-Smith OH, Gooszen HG, Dijkgraaf MG, Boermeester MA; Dutch Pancreatitis Study Group.

BMC Gastroenterol. 2013 Mar 18;13:49. doi: 10.1186/1471-230X-13-49.

8.

Pancreatic cyst development: insights from von Hippel-Lindau disease.

van Asselt SJ, de Vries EG, van Dullemen HM, Brouwers AH, Walenkamp AM, Giles RH, Links TP.

Cilia. 2013 Feb 5;2(1):3. doi: 10.1186/2046-2530-2-3.

9.

Tailored imaging of islet cell tumors of the pancreas amidst increasing options.

Fiebrich HB, van Asselt SJ, Brouwers AH, van Dullemen HM, Pijl ME, Elsinga PH, Links TP, de Vries EG.

Crit Rev Oncol Hematol. 2012 May;82(2):213-26. doi: 10.1016/j.critrevonc.2011.05.006. Epub 2011 Jun 25. Review.

PMID:
21704529
10.

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

Schreurs LM, Janssens AC, Groen H, Fockens P, van Dullemen HM, van Berge Henegouwen MI, Sloof GW, Pruim J, van Lanschot JJ, Steyerberg EW, Plukker JT.

Ann Surg Oncol. 2011 May 6. [Epub ahead of print]

PMID:
21547703
11.

Endoscopic ultrasonography in suspected pancreatic malignancy and indecisive CT.

Meijer OL, Weersma RK, van der Jagt EJ, van Dullemen HM.

Neth J Med. 2010 Sep;68(9):360-4.

12.

Procedure-related, false-positive cytology results during EUS-guided FNA in patients with esophageal cancer.

van Hemel BM, Lamprou AA, Weersma R, Plukker JT, Suurmeijer AJ, van Dullemen HM.

Gastrointest Endosc. 2010 Jun;71(7):1130-3. doi: 10.1016/j.gie.2010.01.051.

PMID:
20598243
13.

Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy.

Smit JK, Pultrum BB, van Dullemen HM, Van Dam GM, Groen H, Plukker JT.

Am J Surg. 2010 Oct;200(4):446-53. doi: 10.1016/j.amjsurg.2009.12.006. Epub 2010 Apr 20.

PMID:
20409512
14.

A critical appraisal of circumferential resection margins in esophageal carcinoma.

Pultrum BB, Honing J, Smit JK, van Dullemen HM, van Dam GM, Groen H, Hollema H, Plukker JT.

Ann Surg Oncol. 2010 Mar;17(3):812-20. doi: 10.1245/s10434-009-0827-4.

15.

Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study.

Pultrum BB, van der Jagt EJ, van Westreenen HL, van Dullemen HM, Kappert P, Groen H, Sietsma J, Oudkerk M, Plukker JT, van Dam GM.

Cancer Imaging. 2009 Apr 6;9:19-28. doi: 10.1102/1470-7330.2009.0004.

16.

Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study).

van den Broek FJ, de Graaf EJ, Dijkgraaf MG, Reitsma JB, Haringsma J, Timmer R, Weusten BL, Gerhards MF, Consten EC, Schwartz MP, Boom MJ, Derksen EJ, Bijnen AB, Davids PH, Hoff C, van Dullemen HM, Heine GD, van der Linde K, Jansen JM, Mallant-Hent RC, Breumelhof R, Geldof H, Hardwick JC, Doornebosch PG, Depla AC, Ernst MF, van Munster IP, de Hingh IH, Schoon EJ, Bemelman WA, Fockens P, Dekker E.

BMC Surg. 2009 Mar 13;9:4. doi: 10.1186/1471-2482-9-4.

17.

Colonoscopy training for nurse endoscopists: a feasibility study.

Koornstra JJ, Corporaal S, Giezen-Beintema WM, de Vries SE, van Dullemen HM.

Gastrointest Endosc. 2009 Mar;69(3 Pt 2):688-95. doi: 10.1016/j.gie.2008.09.028.

PMID:
19251011
18.

A safe technique for removing a malpositioned covered biliary self-expandable metal stent.

Koornstra JJ, van Dullemen HM, Weersma RK.

Endoscopy. 2008 Sep;40 Suppl 2:E165. doi: 10.1055/s-2007-995791. No abstract available.

PMID:
18668454
19.

Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.

Weersma RK, Zhou L, Nolte IM, van der Steege G, van Dullemen HM, Oosterom E, Bok L, Peppelenbosch MP, Faber KN, Kleibeuker JH, Dijkstra G.

Inflamm Bowel Dis. 2008 Dec;14(12):1615-22. doi: 10.1002/ibd.20610.

PMID:
18668679
20.

[Diagnostics and treatment of cholangiocarcinoma].

Mantel HT, Verdonk RC, van Dullemen HM, Gietema JA, Slooff MJ, Porte RJ.

Ned Tijdschr Geneeskd. 2008 May 3;152(18):1037-41. Review. Dutch.

PMID:
18547024
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk